Petros Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $1,421 | $1,388 | $-364 | $1,674 |
Gross Profit | 374 | 1,056 | -522 | 1,266 |
EBITDA | -1,526 | -1,565 | -3,979 | |
EBIT | -2,280 | -2,318 | -4,806 | |
Net Income | -662 | -8,026 | 318 | -4,549 |
Net Change In Cash | 1,421 | 1,388 | -364 | 1,674 |
Free Cash Flow | -1,662 | -1,134 | -2,259 | -3,691 |
Cash | 7,460 | 11,080 | 13,336 | 17,969 |
Basic Shares | 7,388 | 4,756 | 2,991 | 2,119 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $5,822 | $5,992 | $7,811 | $9,559 |
Gross Profit | 908 | 3,702 | 6,211 | 5,513 |
EBITDA | -7,347 | -6,842 | -11,170 | -10,621 |
EBIT | -10,762 | -12,558 | -18,151 | -17,374 |
Net Income | -8,163 | -27,037 | -9,355 | -20,585 |
Net Change In Cash | 5,822 | 5,992 | 7,811 | 9,559 |
Free Cash Flow | -7,626 | -12,797 | -11,862 | -15,309 |
Cash | 13,336 | 9,426 | 23,847 | 17,139 |
Basic Shares | 2,176 | 2,070 | 1,088 | 970 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.37 |
2024-03-31 | -$1.69 |
2023-12-31 | -$2.29 |
2023-09-30 | -$2.30 |
